Journal of Molecular and Cellular Cardiology Plus

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Molecular and Cellular Cardiology Plus is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,470 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2772-9761
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,470 USD
Articles in DOAJ
332
Declared review time
14 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2023-09-08
Indexing
DOAJ
APC
2,470 USD
Declared review time (DOAJ)
14 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

332

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

736

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

9

i10-index

8

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2023-09-08
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
20%
ORCID iDs in current deposits
2%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
JMCC PLUS
Source type
journal
NLM unique ID (PubMed)
9918470779706676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system

LCC codes

RC666-701

Subject areas

  • Cardiac Fibrosis and Remodeling
  • Cardiac Fibrosis and Remodeling
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Function and Risk Factors
  • Cardiomyopathy and Myosin Studies
  • Cardiomyopathy and Myosin Studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
Show all subjects (50)
  • Congenital heart defects research
  • Congenital heart defects research
  • Mitochondrial Function and Pathology
  • Mitochondrial Function and Pathology
  • Cardiac Ischemia and Reperfusion
  • Cardiac Ischemia and Reperfusion
  • Adipose Tissue and Metabolism
  • Adipose Tissue and Metabolism
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
  • Cardiovascular Effects of Exercise
  • Cardiovascular Effects of Exercise
  • Heart Failure Treatment and Management
  • Heart Failure Treatment and Management
  • Viral Infections and Immunology Research
  • Viral Infections and Immunology Research
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • Diabetes Treatment and Management
  • Nitric Oxide and Endothelin Effects
  • Diabetes Treatment and Management
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Nitric Oxide and Endothelin Effects
  • Atherosclerosis and Cardiovascular Diseases
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Disease and Adiposity
  • Ion channel regulation and function
  • Ion channel regulation and function
  • Pulmonary Hypertension Research and Treatments
  • Adipokines, Inflammation, and Metabolic Diseases
  • Pulmonary Hypertension Research and Treatments
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Protein Kinase Regulation and GTPase Signaling
  • Protein Kinase Regulation and GTPase Signaling

Keywords (DOAJ)

  • cardiovascular disease
  • heart
  • atherosclerosis
  • cardiomyopathy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: